FIELD: medicine.
SUBSTANCE: there is offered to apply 4-(2-hydroxyethyl)phenol(n-thyrozol) as a medicinal agent with anti-ischemic properties.
EFFECT: intravenous introduction of n-thyrozol improves the survival rate of animals with old myocardial ischemia and reperfusion, reduces a region of myocardial ischemia, and enables higher integrity of myocardial tissue.
3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
ANTI-ISCHEMIC DRUG | 2012 |
|
RU2499593C1 |
AGENT POSSESSING ENDOTHELIUM PROTECTIVE ACTIVITY | 2014 |
|
RU2563622C1 |
MEANS IMPROVING MICROVASCULARIZATION IN BRAIN TISSUE | 2017 |
|
RU2650624C1 |
AGENT RELIEVING POSTINFARCTION MYOCARDIAL REMODELING | 2020 |
|
RU2740895C1 |
AGENT STIMULATING NEUROGENESIS IN ISCHEMIC CEREBRAL INJURIES | 2015 |
|
RU2585094C1 |
AGENT WITH CARDIOPROTECTIVE ACTIVITY | 2019 |
|
RU2791641C2 |
MEDICATION FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2014 |
|
RU2555335C9 |
NEUROPROTECTOR | 2009 |
|
RU2406488C1 |
AGENT FOR TREATMENT OF PATIENT WITH HEART ISCHEMIC DISEASE | 1998 |
|
RU2155036C2 |
AGENT POSSESSING NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2701739C1 |
Authors
Dates
2010-03-20—Published
2008-11-11—Filed